Account
Zenith India bags media mandate for Zoomcar
Mumbai: Zenith, the ROI agency under Publicis Groupe has bagged the media mandate for car sharing platform Zoomcar, following a multi-agency pitch.
With its deep-seated media planning and buying, Zenith aims to strengthen and elevate Zoomcar’s marketing efforts in India, it said in a statement.
As a part of the mandate, Zenith will handle the entire gamut of media planning including brand strategy, media buying and implementation. “The scope of work will be ROI driven with data analytics as its core. Through this association, Zenith expects to help expand Zoomcar as a brand to a larger audience and build a strong media presence in the market,” said the agency.
“In a progressing market, we aim to give the best data analytics experience to our clients. Our ROI led strategic media approach will aid the company’s growth in India,” stated Zenith India CEO Jai Lala.
“We are happy to partner with Zenith to help bolster our marketing strategies in India,” commented Zoomcar India CEO Nirmal NR. “We look forward to a fruitful association and believe that the agency with its innovative ideas and inherent data analytics, media planning and buying knowledge will help with our business growth.”
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
